ADVERTISEMENT
Conference Coverage
Florian Rieder, MD, on Anti-TNF Biosimilars for IBD
08/27/2022
Dr Rieder reviews his presentation from the AIBD virtual regional meeting on August 27 on biosimilars for anti-tumor necrosis factor therapies, including ways to overcome the "nocebo effect" among patients.
Florian Rieder, MD, is vice chair of gastroenterology and co-section head of the Inflammatory Bowel Disease Center at Cleveland Clinic in Cleveland, Ohio.